3-(1H-imidazol-1-yl)cyclohexan-1-amine, 95.0%, 250mg

1-Boc-4-Mercapto-piperidine, 98.0%, 5g

1-(Benzyloxy)-2-isocyanobenzene, 98%, 1g

3-Bromo-4-nitrobenzaldehyde, 98.0%, 5g

EDTA copper disodium salt x H2O, min. 99%, for synthesis, 1 kg, plastic packaging.

1-(4-Chloropyridin-2-yl)-N-methylmethanamine, 95.0%, 5g

2-([1,1':3',1''-Terphenyl]-4-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 200mg

Ethyl 4,4,4-trifluoroacetoacetate, 98.00%, 100g

Tert-butyln-{[3-(hydroxymethyl)oxetan-3-yl]methyl}carbamate, 98%, 100mg

1-(4-Fluorophenyl)dihydro-2,4(1H,3H)-pyrimidinedione, 10g

2-(R)-Dibenzylaminopropan-1-ol, 97%, 250mg

2,5-Dibromobenzotrifluoride, 98.0%, 100g

GC capillary column ROTI®Cap-624, 30 m, 0.25 mm, 1.40 µm, 1 Piece(s)